AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
Migrate infobox: document_type -> document_category; add specific form as document_type |
||
| (15 intermediate revisions by the same user not shown) | |||
Line 4:
| period = FY
| period_label = FY25
|
| publication_date = 2026-02-26
| language = English
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| intro_sentence = This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.
}}
Line 19 ⟶ 18:
=== Full Year 2025 earnings presentation ===
* ''AXA Full Year 2025'' earnings presentation delivered on February
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
*
*
* ''Risk factors'' and uncertainties that may affect AXA's business are described in Part 5 "Risk Factors and Risk Management" of AXA's 2024 Universal Registration Document <sup>p. 2</sup>.
* ''Alternative performance measures'' (APMs) used include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
** APMs are defined under ESMA guidelines and the AMF's 2015 position statement, with reconciliations provided in AXA's 2025 Activity Report <sup>p. 2</sup>.
*
=== Table of contents ===
* ''
* ''
* ''
== FY25 Highlights ==
* Section divider slide for ''FY25 Highlights'', presented by Thomas Buberl, Group CEO <sup>p. 4</sup>.
=== Full Year 2025 | Excellent performance ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Metric
! class="col-m" style="text-align:right" | Value
|-
| style="text-align:left" | Revenues growth vs. FY24
| style="text-align:right" | +6%
|-
| style="text-align:left" | Underlying EPS growth vs. FY24
| style="text-align:right" | +8%
|-
| style="text-align:left" | Return on equity
| style="text-align:right" | 16%
|-
| style="text-align:left" | Solvency II ratio
| style="text-align:right" | 224%
|-
| style="text-align:left" | DPS growth
| style="text-align:right" | +8%
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | EUR 1.25bn
|-
| style="text-align:left" | Underlying EPS outlook for 2026
| style="text-align:right" | Upper end of 6%-8% target range
|}
</div>
* Dividend proposal based on Board of Directors' recommendation on February 25, 2026, subject to Shareholders' Annual General Meeting approval on April 30, 2026
* Share buyback approved by the Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable, subject to market conditions
=== Executing the plan on growth, margin and efficiency ===
Line 68 ⟶ 76:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings,
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
| style="text-align:right" | +9%
|}
</div>
* High organic growth: +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%)
* Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency
* Scaling the business: Continued investments in growth and technology
* Consistent earnings growth while enhancing reserve prudence
=== Diversified franchise, well positioned in an attractive industry ===
Line 104 ⟶ 99:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 116 ⟶ 111:
| style="text-align:left" | Large & Specialty
| style="text-align:right" | 17%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|}
</div>
* ''Our right to win'' is supported by four strategic pillars:
** Leading brand & high customer NPS
** Strong and diversified distribution
** Technical expertise to price & underwrite risks
** Scale offering cost advantage
=== Laying the foundation for the next plan ===
* ''Strategic pillars'' established to lay the foundation for the next plan:
*
**
*
**
* ''Earnings growth'' outlook supported by strong foundations, providing confidence in sustaining earnings growth <sup>p. 8</sup>
== Business Performance ==
=== FY25 business performance ===
* ''Section 2'': FY25 Business Performance presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>.
=== Strong delivery across our businesses ===
* ''Premium growth basis'': change for gross written premiums is at constant scope and FX <sup>p. 10</sup>.
* ''Earnings growth basis'': change for underlying earnings is at constant FX <sup>p. 10</sup>.
* ''Total GWP definition'': FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
<div style="overflow-x:auto">
{| class="wikitable"
|+
! style="text-align:left" | Region (share of total GWP¹)
! class="col-m" style="text-align:right" |
! class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''France'' (27% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''Europe'' (38% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''AXA XL'' (17% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|-
| style="text-align:left" | ''Asia, Africa & EME-LATAM'' (18% of total GWP¹)
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
|}
</div>
=== P&C | Strong margins, confidence in sustaining growth ===
* ''
* (donut)
**
* ''Retail and SME & Mid-market'' strategic outlook:
*
** ''
*
** ''
* ''Earnings drivers'' supporting performance:
**
**
**
=== L&H | Good momentum, well positioned to capture growth opportunities ===
* ''Gross written premiums'' (GWP) reached EUR 57bn <sup>p. 12</sup>.
* (donut) ''GWP mix'': Short-term and Long-term segments — shares not labeled <sup>p. 12</sup>.
* ''Underlying earnings'' +7% LFL to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>.
* ''Long-term business'' strategic priorities:
** ''2025'': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>.
** ''Beyond 2025'': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>.
* ''Short-term business'' strategic priorities:
** ''2025'': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>.
** ''Beyond 2025'': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>.
* ''Strategic levers'' for growth and efficiency:
** Focus on cost reduction <sup>p. 12</sup>.
** Increasing penetration of Protection riders in Savings offerings <sup>p. 12</sup>.
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>.
== Financial Performance ==
=== FY25 financial performance ===
* ''Section 3'': FY25 Financial Performance presented by Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
=== P&C | Continued disciplined growth ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C GWP
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 35.8
| style="text-align:right" | +4%
| style="text-align:right" | +2%
| style="text-align:right" | +2%
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 2.6
| style="text-align:right" | +8%
| style="text-align:right" | +0.3%
| style="text-align:right" | +7%
|-
| style="text-align:left" | Retail lines
| style="text-align:right" | —
| style="text-align:right" | 19.7
| style="text-align:right" | +7%
| style="text-align:right" | +5%
| style="text-align:right" | +2%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 56.5
| style="text-align:right; font-weight:bold" | 58.0
| style="text-align:right; font-weight:bold" | +5%
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
|}
</div>
* Continued pricing momentum and volume growth in Mid-market and SME
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance
* Growth supported by alternative capital
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Combined ratio
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
| style="text-align:right" | 67.4%
| style="text-align:right" | 67.0%
|-
| style="text-align:left" | Expense ratio
| style="text-align:right" | 25.0%
| style="text-align:right" | 24.8%
|-
| style="text-align:left" | Nat Cat
| style="text-align:right" | 3.8%
| style="text-align:right" | 3.4%
|-
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left; font-weight:bold" | Total combined ratio
| style="text-align:right; font-weight:bold" | 91.0%
| style="text-align:right; font-weight:bold" | 90.6%
|}
</div>
* Undiscounted CY loss ratio (ex Nat Cat) improved from:
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management
* Expense ratio improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology
* Nat Cat charges below normalized load
* Prior year reserve development shows lower reliance
* Reserve prudence enhanced by taking advantage of a good year
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 277 ⟶ 304:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
| style="text-align:right" | 5,510
|-
| style="text-align:left" | Volume growth
| style="text-align:right" | +292
|-
| style="text-align:left" | Margin improvement
| style="text-align:right" | +189
|-
| style="text-align:left" | Investment income
| style="text-align:right" | +435
|-
| style="text-align:left" | Insurance finance expenses
| style="text-align:right" | -235
|-
| style="text-align:left" | Tax
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates, FX & other
| style="text-align:right" | -150
|-
| style="text-align:left" | FY25
| style="text-align:right" | 5,872
|}
</div>
*
*
*
*
*
=== Life & Health | Strong growth in premiums, positive net flows ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | Life GWP
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | 17.3
| style="text-align:right" | +11%
|-
| style="text-align:left" | Unit-linked
| style="text-align:right" | —
| style="text-align:right" | 9.3
| style="text-align:right" | +13%
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | —
| style="text-align:right" | 9.0
| style="text-align:right" | +7%
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
|-
| style="text-align:left" | Health GWP
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
| style="text-align:right" | +5%
|-
| style="text-align:left" | Individual
| style="text-align:right" | —
| style="text-align:right" | 10.5
| style="text-align:right" | +6%
|-
| style="text-align:left" | Group
| style="text-align:right" | —
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
|-
| style="text-align:left" | Employee Benefits GWP
| style="text-align:right" | —
| style="text-align:right" | 12.9
| style="text-align:right" | +4%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net flows by segment, FY24 vs FY25 <sup>p. 17</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 1.5
| style="text-align:right; font-weight:bold" | 5.4
|-
| style="text-align:left" | Protection
| style="text-align:right" | —
| style="text-align:right" | 4.9
|-
| style="text-align:left" | Health
| style="text-align:right" | —
| style="text-align:right" | 2.7
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | —
| style="text-align:right" | 1.5
|-
| style="text-align:left" | Capital light G/A
| style="text-align:right" | —
| style="text-align:right" | 1.2
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | -5.0
|}
</div>
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left; font-weight:bold" | Total PVEP
| style="text-align:right; font-weight:bold" | 50.9
| style="text-align:right; font-weight:bold" | 49.4
| style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
| style="text-align:right" | —
| style="text-align:right" | 31.4
| style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-Linked
| style="text-align:right" | —
| style="text-align:right" | 8.5
| style="text-align:right" | +18%
|-
| style="text-align:left" | Capital-light G/A
| style="text-align:right" | —
| style="text-align:right" | 7.8
| style="text-align:right" | -10%
|-
| style="text-align:left" | Traditional G/A
| style="text-align:right" | —
| style="text-align:right" | 1.7
| style="text-align:right" | -10%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | NB CSM (pre-tax)
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|-
| style="text-align:left" | NBV (post-tax)
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|}
</div>
* ''PVEP'' impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>.
* ''NB CSM'' driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>.
* ''NBV'' broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>.
* ''NBV margin'': 4.4% in FY24 → 4.5% in FY25 <sup>p. 18</sup>
=== Life & Health | Growth in new business driving Normalized CSM growth ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | FY24
| style="text-align:right" | 33.6
|-
| style="text-align:left" | New business CSM
| style="text-align:right" | +2.2
|-
| style="text-align:left" | Underlying return on in-force
| style="text-align:right" | +1.3
|-
| style="text-align:left" | CSM release
| style="text-align:right" | -3.0
|-
| style="text-align:left" | Economic variance
| style="text-align:right" | +0.6
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -0.3
|-
| style="text-align:left" | Affiliates, FX & other
| style="text-align:right" | -1.4
|-
| style="text-align:left" | FY25
| style="text-align:right" | 33.0
|}
</div>
* ''Normalized CSM'' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>
* ''Economic variance'' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
* ''Operating variance'' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
* ''FX impact'' mainly from JPY and HKD depreciation <sup>p. 19</sup>
* (waterfall) ''Contractual Service Margin rollforward'' (in EUR billion): FY24 EUR 33.6bn (o/w Life EUR 25.8bn, o/w Health EUR 7.7bn) → New business CSM +EUR 2.2bn → Underlying return on in-force +EUR 1.3bn → CSM release -EUR 3.0bn (Normalized CSM growth +2%) → Economic variance +EUR 0.6bn → Operating variance -EUR 0.3bn → Affiliates, FX & other -EUR 1.4bn → FY25 EUR 33.0bn (o/w Life EUR 25.4bn, o/w Health EUR 7.6bn) <sup>p. 19</sup>
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 404 ⟶ 535:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24 start
| style="text-align:right" | 3,323
|-
| style="text-align:left" | Short-term technical margin
| style="text-align:right" | +60
|-
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | +156
|-
| style="text-align:left" | Financial result
| style="text-align:right" | -11
|-
| style="text-align:left" | Tax, FX and others
| style="text-align:right" | -27
|-
| style="text-align:left" | FY25 end
| style="text-align:right" | 3,501
|}
</div>
* ''Underlying earnings'' +7% LFL to EUR 3,501m <sup>p. 20</sup>
* ''Short-term technical margin'': EUR 415m in FY24 to EUR 479m in FY25 <sup>p. 20</sup>
* ''Long-term result'' incl. CSM release: EUR 2,680m in FY24 to EUR 2,804m in FY25 <sup>p. 20</sup>
* ''Financial result'': EUR 975m in FY24 to EUR 946m in FY25 <sup>p. 20</sup>
* ''Tax & others'': EUR -748m in FY24 to EUR -728m in FY25 <sup>p. 20</sup>
* ''Life underlying earnings'' +4% to EUR 2.7bn (prior: EUR 2.6bn) <sup>p. 20</sup>
* ''Health underlying earnings'' +17% to EUR 0.8bn (prior: EUR 0.7bn) <sup>p. 20</sup>
* ''Short-term margin'' strong on underwriting and claims initiatives; more than offset legislative change on Mexico VAT recoverability of EUR -0.1bn <sup>p. 20</sup>
* ''Long-term results'' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins <sup>p. 20</sup>
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 453 ⟶ 573:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Property & Casualty
| style="text-align:right" |
| style="text-align:right" | 5.9
| style="text-align:right" | +9%
|-
| style="text-align:left" | Life & Health
| style="text-align:right" |
| style="text-align:right" | 3.5
| style="text-align:right" | +7%
|-
| style="text-align:left" | Asset Management
| style="text-align:right" |
| style="text-align:right" | 0.2
| style="text-align:right" | -57%
|-
| style="text-align:left" | Holdings & other
| style="text-align:right" | -1.2
| style="text-align:right" |
| style="text-align:right" | -
|-
| style="text-align:left" | ''
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | +
|-
| style="text-align:left" | Non-financial flows
Line 494 ⟶ 609:
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" |
| style="text-align:right" |
| style="text-align:right" | +2.2
| style="text-align:right" | —
Line 503 ⟶ 618:
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left" | ''Net income''
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|}
</div>
* ''Underlying earnings'' drivers:
** Strong performance from insurance businesses <sup>p. 21</sup>
** Stable holding cost, expected to remain at current level in 2026 <sup>p. 21</sup>
* ''Net income'' drivers:
** Higher net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
** Lower financial flows reflecting unfavorable forex impact <sup>p. 21</sup>
* Change is at constant FX for underlying earnings and net income; change is on a reported basis for underlying earnings per share <sup>p. 21</sup>
* (bar) ''Underlying earnings per share'' (In Euro): EUR 3.59 in FY24 to EUR 3.86 in FY25 (+8%) <sup>p. 21</sup>
=== Shareholders' equity ===
* (stacked bar) ''Shareholders' equity'' Group share:
** ''FY24'': EUR 49.9bn total (comprising SHE excl. OCI EUR 58.0bn and Net OCI EUR -8.1bn) <sup>p. 22</sup>
** ''HY25'': EUR 45.5bn total (comprising SHE excl. OCI EUR 52.7bn and Net OCI EUR -7.2bn) <sup>p. 22</sup>
** ''FY25'': EUR 47.2bn total (comprising SHE excl. OCI EUR 54.0bn and Net OCI EUR -6.8bn) <sup>p. 22</sup>
* ''SHE (excl. OCI & undated subordinated debt)'': EUR 53.2bn in FY24 → EUR 47.0bn in HY25 → EUR 49.4bn in FY25 <sup>p. 22</sup>
* ''Debt gearing'': 20.6% in FY24 → 23.4% in HY25 → 22.3% in FY25 <sup>p. 22</sup>
* ''Underlying ROE'': 15.2% in FY24 → 17.5% in HY25 → 16.0% in FY25 <sup>p. 22</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" |
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
Line 577 ⟶ 692:
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" |
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" |
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
Line 599 ⟶ 714:
| style="text-align:right" | 0.3
|-
| style="text-align:left" |
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
=== Higher organic cash remittance and robust cash position at Holding ===
* (bar) ''Net cash remittance'' trend:
** ''FY24'': EUR 7.7bn total, comprising EUR 7.1bn ordinary remittance and EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
** ''FY25'': EUR 7.5bn total <sup>p. 23</sup>
* ''Remittance ratio'' remained stable at 82% in FY24 and 82% in FY25, based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | ''FY24 Cash position''
| style="text-align:right" | 4.0
|-
| style="text-align:left" | Net cash remittance from subsidiaries
| style="text-align:right" | +7.5
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Holding costs and interest expenses
| style="text-align:right" | -1.3
|-
| style="text-align:left" | Change in net debt
| style="text-align:right" | +1.6
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|}
</div>
=== Solvency II at 224% ===
Line 645 ⟶ 766:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Solvency II ratio (pts)
|-
| style="text-align:left" |
| style="text-align:right" | 55.9
| style="text-align:right" | 25.9
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | +0
|-
| style="text-align:left" | Normalized capital generation
| style="text-align:right" | +8.8
| style="text-align:right" | +0.6
| style="text-align:right" | +28
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -0.4
| style="text-align:right" | 0.0
| style="text-align:right" | -1
|-
| style="text-align:left" | Economic variance & FX
| style="text-align:right" | -2.1
| style="text-align:right" | -1.2
| style="text-align:right" | +4
|-
| style="text-align:left" | Dividend & annual share buyback
| style="text-align:right" | -6.0
| style="text-align:right" | 0.0
| style="text-align:right" | -24
|-
| style="text-align:left" | Management actions, debt & other
| style="text-align:right" | -0.1
| style="text-align:right" | -0.2
| style="text-align:right" | +2
|-
| style="text-align:left" | FY25
| style="text-align:right" | 56.4
| style="text-align:right" | 25.2
| style="text-align:right" | 224
|}
</div>
* Foreseeable dividends accounted for -EUR 4.8bn.
* Provision for annual share buyback for 2026 accounted for -EUR 1.25bn.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key sensitivities
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 695 ⟶ 838:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity (
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity (
| style="text-align:right" | +2
|-
Line 712 ⟶ 855:
</div>
*
*
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 719 ⟶ 862:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II
! style="text-align:left" |
! class="col-
|-
| style="text-align:left" |
| style="text-align:right" | 224
|-
| style="text-align:left" |
| style="text-align:right" | -
|-
| style="text-align:left" |
| style="text-align:right" | +
|}
</div>
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026
* No change is expected in organic capital generation
*
*
* ''Grandfathering end impact'' on January 1, 2026 is -10pts to 215% <sup>p. 25</sup>.
=== Thomas Buberl, Group CEO conclusion ===
*
=== Conclusion ===
*
* ''All businesses'' in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>.
*
* ''Laying foundations'' for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>.
=== February 26, 2026 Q&A Full Year 2025 earnings ===
* ''Q&A session'' for the Full Year 2025 Earnings presentation held on February 26, 2026 <sup>p. 28</sup>.
=== AXA Investor Relations | Keep in touch ===
* ''
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Date
! class="col-m" style="text-align:right" | Event
! class="col-m" style="text-align:right" | Location
|-
| style="text-align:left" | March
| class="col-m" style="text-align:right" | Roadshows
| class="col-m" style="text-align:right" | Europe and US
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>
== Appendices ==
=== Table of contents ===
*
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1st 2026
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 3.2
|-
| style="text-align:left
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 11.3
|-
| style="text-align:left
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 5.8
|-
| style="text-align:left;
| style="text-align:right; font-weight:bold" |
| style="text-align:right; font-weight:bold" |
| style="text-align:right; font-weight:bold" | 20.3
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Contractual maturity breakdown <sup>p. 32</sup>
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
! class="col-s" style="text-align:right" | Senior debt
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.5
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.9
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 1.5
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.5
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 Undated
| style="text-align:right" | 1.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 2030
| style="text-align:right" | —
| style="text-align:right" | 0.7
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 2 ≥2040
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Tier 2
|-
| style="text-align:left" |
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | 2.4
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.5
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | 2.0
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.9
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 1.5
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 0.5
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 0.1
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Tier 1 2031-2039
| style="text-align:right" | 0.4
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:right" | —
| style="text-align:right" | 0.2
| style="text-align:right" | —
|}
</div>
* In January 2026, AXA called the remaining Tier 2 grandfathered GBP 139m due 2054 callable 2034 (5.625% issued January 2014) and the Tier 1 grandfathered EUR 250m perpetual callable 2010 floating (issued January 2005).
* Economic maturity accounts for the first date of step-up calls on institutionally placed subordinated debt.
* For Solvency II RT1 debt with no step-up, the undated nature of the instrument is retained for economic maturity.
=== General account invested assets ===
* ''Total General Account'' invested assets at EUR 450bn <sup>p. 33</sup>.
* ''Duration gap'' at -0.4 year <sup>p. 33</sup>.
* (donut) ''FY25 General Account invested assets'': EUR 450bn total; mix includes Fixed income, Real estate, Infrastructure equity, Listed equities, Private equity and hedge funds, Cash, and Policy loans <sup>p. 33</sup>.
* ''Other fixed income'' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn), and Agency Pools (EUR 8bn) <sup>p. 33</sup>.
* ''Listed equities'' includes hedges; listed equities excluding hedges at EUR 14bn <sup>p. 33</sup>.
* ''Private equity and hedge funds'' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn), and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | %
|-
| style="text-align:left" | ''Fixed income''
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left" | ''o/w Government bonds''
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left" | ''o/w Corporate bonds and loans''
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left" | ''o/w Other fixed income''
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | ''Real estate''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | ''Infrastructure equity''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Listed equities''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | ''Private equity and hedge funds''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | ''Cash''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | ''Policy loans''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" | ''Total Insurance Invested Assets''
| style="text-align:right" | 450
| style="text-align:right" | 100%
|}
</div>
=== Structured and private credit assets ===
* ''Total structured and private credit assets'' stood at EUR 69bn, representing 15% of the total General Account portfolio, with 54% participating <sup>p. 34</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured and private credit assets breakdown FY25 <sup>p. 34</sup>
! style="text-align:left" | Invested assets (100%) in EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
! class="col-m" style="text-align:right" | Comments
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO & ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left" | ''Total Structured and Private Credit Assets''
| style="text-align:right" | ''69''
| style="text-align:right" | ''15%''
| style="text-align:right" | o/w 54% participating
|}
</div>
* ''General Account'' (G/A) represents the investment portfolio <sup>p. 34</sup>.
=== Investment portfolio | Fixed income reinvestment ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment asset mix <sup>p. 35</sup>
! style="text-align:left" | Asset mix
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
|}
</div>
Line 990 ⟶ 1,266:
{| class="wikitable fintable"
|+ FY25 Fixed Income Reinvestment Yield <sup>p. 35</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" | Yield
|-
Line 1,003 ⟶ 1,279:
|}
</div>
* Fixed income reinvestment totaled EUR 57bn in FY25 <sup>p. 35</sup>
* Reinvestment yield achieved at 3.9% on EUR 57bn fixed income <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
**
**
=== Table of contents ===
* ''Debt and Invested Assets'' on page 31 <sup>p. 36</sup>
* ''Additional P&C disclosures'' on page 36 <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' on page 41 <sup>p. 36</sup>
* ''Sustainability'' on page 44 <sup>p. 36</sup>
=== AXA XL Insurance | Large Commercial & Specialty business ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP by geography <sup>p. 37</sup>
! style="text-align:left" | Geography
! class="col-s" style="text-align:right" | Share
|-
| style="text-align:left" | Americas
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | 19%
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Line of business
! class="col-m" style="text-align:right" | Profitability
! class="col-m" style="text-align:right" | Ex-price growth
|-
| style="text-align:left" | Property
| class="col-m" style="text-align:right" | high
| class="col-m" style="text-align:right" | high
|-
| style="text-align:left" | Specialty
| class="col-m" style="text-align:right" | medium-high
| class="col-m" style="text-align:right" | medium-high
|-
| style="text-align:left" | Casualty
| class="col-m" style="text-align:right" | medium
| class="col-m" style="text-align:right" | medium
|-
| style="text-align:left" | Professional lines
| class="col-m" style="text-align:right" | lower
| class="col-m" style="text-align:right" | lower
|}
</div>
* Business diversification is well balanced across lines of business and geographies <sup>p. 37</sup>
* Market leadership positions AXA XL in the top 3 globally for <sup>p. 37</sup>:
** Multinational Programs <sup>p. 37</sup>
** Marine <sup>p. 37</sup>
** Fine Art & Specie <sup>p. 37</sup>
* Cycle management is utilized to deliver consistent profitability <sup>p. 37</sup>
* ''Property'': high profitability, high ex-price growth <sup>p. 37</sup>
* ''Specialty'': medium-high profitability, medium-high ex-price growth <sup>p. 37</sup>
* ''Casualty'': medium profitability, medium ex-price growth <sup>p. 37</sup>
* ''Professional lines'': lower profitability, lower ex-price growth <sup>p. 37</sup>
=== P&C | Focus on reserves ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims
! style="text-align:left" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" |
| style="text-align:right" | 179
| style="text-align:right" | 185
| style="text-align:right" | 193
| style="text-align:right" | 188
| style="text-align:right" | 189
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 198
| style="text-align:right" | 195
| style="text-align:right" | 180
| style="text-align:right" | 175
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | 227
| style="text-align:right" | 233
| style="text-align:right" | 226
| style="text-align:right" | 227
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 234
| style="text-align:right" | 232
| style="text-align:right" | 216
| style="text-align:right" | 210
|}
</div>
* Technical reserves definition includes net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
=== P&C | 2026 Simplified Group Nat Cat reinsurance program 1 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Insurance segment occurrence protection <sup>p. 39</sup>
! style="text-align:left" | EUR
! class="col-s" style="text-align:right" | Retention
! class="col-m" style="text-align:right" | Capacity
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | NA Earthquake
| style="text-align:right" | 600m
| style="text-align:right" | 1.2bn
|-
| style="text-align:left" | Per other perils
| style="text-align:right" | 400m
| style="text-align:right" | Varies by peril type
|}
</div>
* Retention levels remained stable in 2026 compared to 2025 <sup>p. 39</sup>.
* (diagram) ''Reinsurance segment'' (illustrative):
* Covered via ''Alternative Capital & Cat Bonds'' <sup>p. 39</sup>
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | Return period / probability percentile
! class="col-s" style="text-align:right" | EUR billion
|-
| style="text-align:left" | 1/20y (95th percentile)
| style="text-align:right" | -1.2
|-
| style="text-align:left" | 1/10y (90th percentile)
| style="text-align:right" | -0.8
|-
| style="text-align:left" | 1/5y (80th percentile)
| style="text-align:right" | -0.4
|-
| style="text-align:left" | Median (50th percentile)
| style="text-align:right" | +0.1
|-
| style="text-align:left" | 1/5y (20th percentile)
| style="text-align:right" | +0.5
|-
| style="text-align:left" | 1/10y (10th percentile)
| style="text-align:right" | +0.7
|-
| style="text-align:left" | 1/20y (5th percentile)
| style="text-align:right" | +0.8
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
|+ Average expected Nat Cat charges net of reinsurance, pre-tax <sup>p. 40</sup>
! style="text-align:left" | Year
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| class="col-s" style="text-align:right" |
| class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| class="col-s" style="text-align:right" |
| class="col-s" style="text-align:right" |
|}
</div>
* ''More severe years'' result in a negative deviation in ca. 40% of cases <sup>p. 40</sup>.
* ''Less severe years'' result in a positive deviation in ca. 60% of cases <sup>p. 40</sup>.
* Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). <sup>p. 40</sup>
=== Table of contents ===
* ''Debt and Invested Assets'' <sup>p. 31</sup>
* ''Additional P&C disclosures'' <sup>p. 36</sup>
* ''Additional IFRS17 disclosures'' <sup>p. 41</sup>
* ''Sustainability'' <sup>p. 44</sup>
=== P&C | Margin analysis ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C margin analysis and underlying earnings FY25 <sup>p. 42</sup>
! style="text-align:left" | EUR million
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
|-
| style="text-align:left" | Tax
| style="text-align:right" | -2,060
| style="text-align:right" | -169
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | -108
| style="text-align:right" | -10
|-
| style="text-align:left" | ''Underlying Earnings''
| style="text-align:right" | 5,872
| style="text-align:right" | +501
|}
</div>
* ''Gross earned premiums'' EUR 57,656m (+6%) <sup>p. 42</sup>
* ''Undiscounted combined ratio'' 95.2% (-1.0pt); of which Nat Cats was 3.4% (-0.4pt) <sup>p. 42</sup>
* ''Discounting ratio'' -3.5% (+0.0pt in Combined Ratio points) <sup>p. 42</sup>
* ''Net claims reserves'' for current accident year at EUR 19.0bn; duration of 4.0 years; discount rate of 2.8% <sup>p. 42</sup>
* ''PYD ratio'' -1.1% (+0.7pt) <sup>p. 42</sup>
* ''Average assets'' for FY25 at EUR 115bn; asset book yield at 3.5%; reinvestment yield on fixed income assets at 4.3% <sup>p. 42</sup>
* ''Reserves at locked-in rate'' for FY24 at EUR 71bn; liability book yield at 1.9% <sup>p. 42</sup>
* ''Underlying earnings growth'' +9% vs. FY24 at constant FX <sup>p. 42</sup>
* ''Discount rate sensitivity'': FY25 sensitivity to current accident year discount rate changes (parallel shift of the full-year average yield curve):
** +25bps: +EUR 0.2bn <sup>p. 42</sup>
** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* ''Insurance finance expenses'': 2026e pre-tax expected at ~EUR -1.4bn <sup>p. 42</sup>
** Sensitivity of 2026e expenses to changes in 2025 current AY discount: +25bps ~EUR -50m; -25bps ~EUR +50m <sup>p. 42</sup>
=== L&H | Margin analysis ===
* ''L&H margin analysis'' includes scope impact <sup>p. 43</sup>.
* ''Short-term technical margin'' +EUR 60m to EUR 479m, including the recapture of Laya <sup>p. 43</sup>.
* ''Gross earned premiums'' +10% to EUR 17,416m <sup>p. 43</sup>.
* ''All year combined ratio'' 97.2%, improved 0.1pts <sup>p. 43</sup>.
* ''Long-term technical margin'' +EUR 156m to EUR 2,804m <sup>p. 43</sup>.
** ''CSM release'' +EUR 215m to EUR 2,954m <sup>p. 43</sup>.
** ''Technical experience'' decreased EUR 58m to EUR -150m <sup>p. 43</sup>.
* ''Investment income'' (non-VFA only) decreased EUR 1m to EUR 2,484m <sup>p. 43</sup>.
** ''Average assets'' (FY25) at EUR 98bn with an asset book yield of 2.5% and FY25 reinvestment yield on fixed income assets of 3.8% <sup>p. 43</sup>.
* ''Insurance finance expenses'' (non-VFA only) increased EUR 9m to EUR -1,538m <sup>p. 43</sup>.
** ''Reserves at locked-in rate'' (FY24) at EUR 62bn with a liability book yield of 2.5% <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Technical and Financial Results
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Short-term Technical Margin
| style="text-align:right" | 479
| style="text-align:right" | +60
|-
| style="text-align:left" | Long-term Technical Margin
| style="text-align:right" | 2,804
| style="text-align:right" | +156
|-
| style="text-align:left" | Investment Income (non-VFA only)
| style="text-align:right" | 2,484
| style="text-align:right" | -1
|-
| style="text-align:left" | Insurance Finance Expenses (non-VFA only)
| style="text-align:right" | -1,538
| style="text-align:right" | -9
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Underlying Earnings
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying Earnings before tax
| style="text-align:right" | 4,229
| style="text-align:right" | +205
|-
| style="text-align:left" | Tax
| style="text-align:right" | -800
| style="text-align:right" | 65
|-
| style="text-align:left" | Affiliates, Minority interests & Other
| style="text-align:right" | 72
| style="text-align:right" | -51
|-
| style="text-align:left" | Underlying Earnings
| style="text-align:right" | 3,501
| style="text-align:right" | +219
|}
</div>
* ''Underlying earnings growth'' +7% versus FY24 at constant FX <sup>p. 43</sup>.
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" | Baseline
| style="text-align:right" | 33.3
|-
| style="text-align:left" | Interest rates +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" | 0.6
|-
| style="text-align:left" | Sovereign spreads +50bps
| style="text-align:right" | -1.9
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" | 1.9
|-
| style="text-align:left" | Corporate spread +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" | 1.8
|-
| style="text-align:left" | Equities -25%
| style="text-align:right" | -2.2
|}
</div>
===
*
*
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Category
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | Achieved in 2025
|-
| style="text-align:left" | Climate transition financing
| class="col-m" style="text-align:right" | EUR 5bn per year
| class="col-m" style="text-align:right" | EUR 6.4bn
|-
| style="text-align:left" | Community resilience financing
| class="col-m" style="text-align:right" | >EUR 500m per year
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" | Transition underwriting (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" | Climate adaptation solutions (cumulative 2024-2026)
| class="col-m" style="text-align:right" | >20,000
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
| style="text-align:left" | Inclusive insurance customers
| class="col-m" style="text-align:right" | >20m by 2026
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" | Climate adaptation training
| class="col-m" style="text-align:right" | >80,000 employees by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" | Carbon emissions reduction
| class="col-m" style="text-align:right" | -50% by 2030
| class="col-m" style="text-align:right" | -64% against 2019
|-
| style="text-align:left" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of employees by 2026
| class="col-m" style="text-align:right" | 56%
|}
</div>
=== Sustainability Performance & Ratings ===
<div style="overflow-x:auto">
{| class="wikitable"
! style="text-align:left" | Rating Agency
! class="col-s" style="text-align:right" | Score
|-
| style="text-align:left" | S&P Global percentile
| class="col-s" style="text-align:right" | 97th
|-
| style="text-align:left" | MSCI
| class="col-s" style="text-align:right" | AAA
|-
| style="text-align:left" | CDP
| class="col-s" style="text-align:right" | B
|-
| style="text-align:left" | Morningstar Sustainalytics
| class="col-s" style="text-align:right" | 17.0 - Low risk
|-
| style="text-align:left" | FTSE Russell
| class="col-s" style="text-align:right" | 4.3/5
|}
</div>
* The Corporate Sustainability Assessment (CSA) ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (specifically AXA Restricted Shares), with results as of February 6th, 2026 <sup>p. 46</sup>.
* ''Morningstar Sustainalytics rating'': 2025 ESG Risk Rating of 17.0 – Low risk <sup>p. 46</sup>
* ''FTSE Russell score'': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
=== Scope ===
*
*
*
*
**
**
** ''
** ''AXA Mediterranean Holdings'' <sup>p. 47</sup>.
* ''AXA Investment Managers'' (until July 1, 2025) scope includes AXA Investment Managers, Select (previously referred to as Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* ''Accounting standards'' comparative figures going back to 2023 are under IFRS17/9 standards (effective January 1, 2023); figures prior to 2023 have not been restated and are presented under IFRS4 <sup>p. 47</sup>.
=== Glossary ===
*
*
*
*
*
*
* ''New Business Value (NBV)'': the value of newly issued contracts during the current year. It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>
*
* ''New Business Value margin (NBV margin)'': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>
* ''Operating variance'': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes. Operating variance is net of reinsurance <sup>p. 48</sup>
* ''
* ''
* ''Underlying return on in-force'': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
=== February 26, 2026 Thank you Full Year 2025 earnings ===
* ''Closing slide'' for the AXA Full Year 2025 Earnings presentation, dated February 26, 2026 <sup>p. 49</sup>.
== Abbreviations ==
* ''
* ''
* ''
* ''
* ''
* ''AMF'': Autorité des marchés financiers
* ''
* ''
* ''AXA XL'': AXA Corporate Solutions and XL Catlin
* ''
* ''BBA'': Benefit-Bearing Account
* ''
* ''
* ''
* ''CSA'': Corporate Sustainability Assessment
* ''
* ''
* ''DPS'': Dividend Per Share
* ''
* ''
* ''
* ''ESG'': Environmental, Social, and Governance
* ''ESMA'': European Securities and Markets Authority
* ''
* ''
* ''
* ''GAAP'': Generally Accepted Accounting Principles
* ''
* ''GEP'': Gross Earned Premium
* ''
* ''
* ''
* ''
* ''IFRS'': International Financial Reporting Standards
* ''
* ''
* ''LATAM'': Latin America
* ''
* ''LTV'': Loan-to-Value
* ''MSCI'': Morgan Stanley Capital International
* ''
* ''NB CSM'': New Business Contractual Service Margin
* ''
* ''
* ''
* ''OCI'': Other Comprehensive Income
* ''
* ''
* ''PVEP'': Present Value of Expected Profits
* ''
* ''RCG'': Reinsurance Capital Generation
* ''
* ''
* ''
* ''
* ''
* ''
* ''UK'': United Kingdom
* ''US'': United States
* ''VAT'': Value Added Tax
* ''VFA'': Variable Fee Approach
| |||